DONNA BRASIER PINION

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family GREENVILLE, MS NPI 1669669446

General Payments — all program years on this page

$1,791.52

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 114
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $381.32 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $381.3221

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $503.2638
2022 $436.5327
2023 $470.4128
2024 $381.3221

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086329586 Bayer Healthcare Pharmaceuticals Inc. $17.99 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092477377 Boston Scientific Corporation $17.96 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092477379 Boston Scientific Corporation $22.88 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100385997 Novo Nordisk Inc $14.84 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100522549 Novo Nordisk Inc $22.20 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100537385 Novo Nordisk Inc $21.10 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104384815 AstraZeneca Pharmaceuticals LP $23.20 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105536850 AstraZeneca Pharmaceuticals LP $17.79 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105592792 AstraZeneca Pharmaceuticals LP $16.94 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105721024 AstraZeneca Pharmaceuticals LP $17.62 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105808718 AstraZeneca Pharmaceuticals LP $16.63 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117656555 Amgen Inc. $14.79 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131160879 PFIZER INC. $16.71 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131481095 PFIZER INC. $18.09 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132099099 PFIZER INC. $17.03 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132293139 SCPHARMACEUTICALS INC. $14.23 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135612212 Lilly USA, LLC $13.72 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135624711 Lilly USA, LLC $15.85 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135630748 Lilly USA, LLC $18.88 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139536146 Astellas Pharma US Inc $26.69 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153720068 IRONWOOD PHARMACEUTICALS, INC $16.18 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.